Concepedia

Author

Masoto Sakamoto

Fukui Red Cross Hospital

Also Known As

Masoto Sakamoto, Sakamoto Masoto

9

Publications

130

Citations

7

H-Index

12

Concepts

All Affiliations

Fukui Red Cross HospitalZhejiang Cancer HospitalKyoto University
MS

About

Masoto Sakamoto is an author at Fukui Red Cross Hospital specializing in cancer therapeutics, cancer research, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

35

2

Medicine

2

2

35

3

Pathology

2

2

35

4

Cancer Therapeutics

2

2

35

5

Adaptive Radiotherapy

1

1

10

Masoto Sakamoto

×

7

Publications

122

Citations

7

H-Index

YearCitations

Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma

Fangzheng Wang, Chuner Jiang, Zhimin Ye,

Oncotarget

2017

25

Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma

Fangzheng Wang, Quanquan Sun, Chuner Jiang,

Oncotarget

2017

23

Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis

Fangzheng Wang, Quanquan Sun, Chuner Jiang,

Journal of Cancer

2018

21

Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma

Fangzheng Wang, Chuner Jiang, Lei Wang,

Oncotarget

2017

18

Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis

Fangzheng Wang, Chuner Jiang, Ye Zhimin,

Oncotarget

2017

14

Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma

Fangzheng Wang, Chuner Jiang, Wang Lei,

Oncotarget

2016

11

Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients

Fangzheng Wang, Chuner Jiang, Quanquan Sun,

Journal of Cancer

2018

10

Page 1